Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.

Oliveira-Mateos C, Sánchez-Castillo A, Soler M, Obiols-Guardia A, Piñeyro D, Boque-Sastre R, Calleja-Cervantes ME, Castro de Moura M, Martínez-Cardús A, Rubio T, Pelletier J, Martínez-Iniesta M, Herrero-Martín D, Tirado OM, Gentilella A, Villanueva A, Esteller M, Farré L, Guil S.

Nat Commun. 2019 Sep 4;10(1):3979. doi: 10.1038/s41467-019-11910-6.

2.

Resistance of the oyster pathogen Vibrio tasmaniensis LGP32 against grazing by Vannella sp. marine amoeba involves Vsm and CopA virulence factors.

Robino E, Poirier AC, Amraoui H, Le Bissonnais S, Perret A, Lopez-Joven C, Auguet JC, Rubio TP, Cazevieille C, Rolland JL, Héchard Y, Destoumieux-Garzón D, Charrière GM.

Environ Microbiol. 2019 Aug 6. doi: 10.1111/1462-2920.14770. [Epub ahead of print]

PMID:
31386262
3.

Species-specific mechanisms of cytotoxicity toward immune cells determine the successful outcome of Vibrio infections.

Rubio T, Oyanedel D, Labreuche Y, Toulza E, Luo X, Bruto M, Chaparro C, Torres M, de Lorgeril J, Haffner P, Vidal-Dupiol J, Lagorce A, Petton B, Mitta G, Jacq A, Le Roux F, Charrière GM, Destoumieux-Garzón D.

Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14238-14247. doi: 10.1073/pnas.1905747116. Epub 2019 Jun 20.

4.

Immune-suppression by OsHV-1 viral infection causes fatal bacteraemia in Pacific oysters.

de Lorgeril J, Lucasson A, Petton B, Toulza E, Montagnani C, Clerissi C, Vidal-Dupiol J, Chaparro C, Galinier R, Escoubas JM, Haffner P, Dégremont L, Charrière GM, Lafont M, Delort A, Vergnes A, Chiarello M, Faury N, Rubio T, Leroy MA, Pérignon A, Régler D, Morga B, Alunno-Bruscia M, Boudry P, Le Roux F, Destoumieux-Garzόn D, Gueguen Y, Mitta G.

Nat Commun. 2018 Oct 11;9(1):4215. doi: 10.1038/s41467-018-06659-3.

5.

Antiparasitic, structural, pharmacokinetic, and toxicological properties of riparin derivatives.

Mafud AC, Silva MPN, Nunes GBL, de Oliveira MAR, Batista LF, Rubio TI, Mengarda AC, Lago EM, Xavier RP, Gutierrez SJC, Pinto PLS, da Silva Filho AA, Mascarenhas YP, de Moraes J.

Toxicol In Vitro. 2018 Aug;50:1-10. doi: 10.1016/j.tiv.2018.02.012. Epub 2018 Feb 22.

PMID:
29476885
6.

Keep it on the edge: The post-mitotic midbody as a polarity signal unit.

Lujan P, Rubio T, Varsano G, Köhn M.

Commun Integr Biol. 2017 Jul 5;10(4):e1338990. doi: 10.1080/19420889.2017.1338990. eCollection 2017.

7.

Health and Disease Imprinted in the Time Variability of the Human Microbiome.

Martí JM, Martínez-Martínez D, Rubio T, Gracia C, Peña M, Latorre A, Moya A, P Garay C.

mSystems. 2017 Mar 21;2(2). pii: e00144-16. doi: 10.1128/mSystems.00144-16. eCollection 2017 Mar-Apr.

8.
9.

Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.

Rubio T, Köhn M.

Biochem Soc Trans. 2016 Oct 15;44(5):1305-1312. Review.

10.

PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody position.

Luján P, Varsano G, Rubio T, Hennrich ML, Sachsenheimer T, Gálvez-Santisteban M, Martín-Belmonte F, Gavin AC, Brügger B, Köhn M.

J Cell Sci. 2016 Nov 1;129(21):4130-4142. Epub 2016 Sep 21.

11.

Copper homeostasis at the host vibrio interface: lessons from intracellular vibrio transcriptomics.

Vanhove AS, Rubio TP, Nguyen AN, Lemire A, Roche D, Nicod J, Vergnes A, Poirier AC, Disconzi E, Bachère E, Le Roux F, Jacq A, Charrière GM, Destoumieux-Garzón D.

Environ Microbiol. 2016 Mar;18(3):875-88. doi: 10.1111/1462-2920.13083. Epub 2015 Dec 21.

PMID:
26472275
12.

Summaries of Safety Labeling Changes Approved By FDA—Boxed Warnings Highlights January-March 2015.

Rubio T.

Am J Health Syst Pharm. 2015 Jun 1;72(11):900, 902, 904. doi: 10.2146/news150039. No abstract available.

PMID:
25987678
13.

Summaries of safety labeling changes approved by FDA-Boxed Warnings Highlights October-December 2014.

Rubio T.

Am J Health Syst Pharm. 2015 Mar 1;72(5):343. doi: 10.2146/news150018. No abstract available.

PMID:
25694404
14.

Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study.

Portilla J, Arazo P, Crusells J, Pérez-Martínez L, Martínez-Madrid O, Boix V, Moreno J, Navarro V, Rubio T, Reus S, Galera C, Bernal E, Jover F, Amador C, Baño D, Merino E, Saiz-de-la-Hoya P.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19803. doi: 10.7448/IAS.17.4.19803. eCollection 2014.

15.

Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In Portugal.

Pereira C, Rubio TC, Rubio RD.

Value Health. 2014 Nov;17(7):A530-1. doi: 10.1016/j.jval.2014.08.1684. Epub 2014 Oct 26. No abstract available.

16.

Antimicrobial histones and DNA traps in invertebrate immunity: evidences in Crassostrea gigas.

Poirier AC, Schmitt P, Rosa RD, Vanhove AS, Kieffer-Jaquinod S, Rubio TP, Charrière GM, Destoumieux-Garzón D.

J Biol Chem. 2014 Sep 5;289(36):24821-31. doi: 10.1074/jbc.M114.576546. Epub 2014 Jul 17.

17.

Another look at the legal and ethical consequences of pharmacological memory dampening: the case of sexual assault.

Chandler JA, Mogyoros A, Rubio TM, Racine E.

J Law Med Ethics. 2013 Winter;41(4):859-71, Table of Contents. doi: 10.1111/jlme.12096.

PMID:
24446944
18.

AMPKβ subunits: more than just a scaffold in the formation of AMPK complex.

Sanz P, Rubio T, Garcia-Gimeno MA.

FEBS J. 2013 Aug;280(16):3723-33. doi: 10.1111/febs.12364. Epub 2013 Jun 24. Review.

19.

[Hemomediastinum caused by rupture of a bronchial artery aneurysm].

Martínez E, Villar I, Pérez S, León M, Rubio T, García C.

An Sist Sanit Navar. 2013 Jan-Apr;36(1):159-62. Spanish.

20.

Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.

Alfonso A, Redondo M, Rubio T, Del Olmo B, Rodríguez-Wilhelmi P, García-Velloso MJ, Richter JA, Páramo JA, Lecumberri R.

Int J Cancer. 2013 Nov;133(9):2157-64. doi: 10.1002/ijc.28229. Epub 2013 May 29.

21.

Sumoylation of AMPKβ2 subunit enhances AMP-activated protein kinase activity.

Rubio T, Vernia S, Sanz P.

Mol Biol Cell. 2013 Jun;24(11):1801-11, S1-4. doi: 10.1091/mbc.E12-11-0806. Epub 2013 Apr 3.

22.

Teasing and disordered eating behaviors in Spanish adolescents.

Rojo-Moreno L, Rubio T, Plumed J, Barberá M, Serrano M, Gimeno N, Conesa L, Ruiz E, Rojo-Bofill L, Beato L, Livianos L.

Eat Disord. 2013;21(1):53-69. doi: 10.1080/10640266.2013.741988.

PMID:
23241090
23.

Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level.

Romá-Mateo C, Moreno D, Vernia S, Rubio T, Bridges TM, Gentry MS, Sanz P.

BMC Evol Biol. 2011 Jul 28;11:225. doi: 10.1186/1471-2148-11-225.

24.

Identification of a novel mutation, I403T, in Cuban type 1 Gaucher disease.

Lavaut K, Rubio T, Collazo T, Esperón AA, Reyes L, Collazo T, Acanda AM.

Blood Cells Mol Dis. 2011 Apr 15;46(4):327. doi: 10.1016/j.bcmd.2011.02.002. No abstract available.

PMID:
21411350
25.

Usefulness of Video-EEG monitoring in patients with drug-resistant epilepsy.

Villanueva V, Gutiérrez A, García M, Beltrán A, Palau J, Conde R, Smeyers P, Rubio P, Gómez E, Rubio T, Sanjuán A, Avila C, Martínez JC, Belloch V, Pérez-Velasco R, Campo A, Domínguez J.

Neurologia. 2011 Jan-Feb;26(1):6-12. doi: 10.1016/j.nrl.2010.09.029. Epub 2010 Dec 8. English, Spanish.

26.

Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children.

Freeman AF, Olivier KN, Rubio TT, Bartlett G, Ochi JW, Claypool RJ, Ding L, Kuhns DB, Holland SM.

Pediatr Pulmonol. 2009 Nov;44(11):1051-6. doi: 10.1002/ppul.21069.

27.

Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.

Vernia S, Rubio T, Heredia M, Rodríguez de Córdoba S, Sanz P.

PLoS One. 2009 Jun 16;4(6):e5907. doi: 10.1371/journal.pone.0005907.

28.

Optimizing electroporation conditions in primary and other difficult-to-transfect cells.

Jordan ET, Collins M, Terefe J, Ugozzoli L, Rubio T.

J Biomol Tech. 2008 Dec;19(5):328-34.

29.

AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

Vernia S, Solaz-Fuster MC, Gimeno-Alcañiz JV, Rubio T, García-Haro L, Foretz M, de Córdoba SR, Sanz P.

J Biol Chem. 2009 Mar 27;284(13):8247-55. doi: 10.1074/jbc.M808492200. Epub 2009 Jan 26.

30.

Increased potency and longevity of gene silencing using validated Dicer substrates.

Hefner E, Clark K, Whitman C, Behlke MA, Rose SD, Peek AS, Rubio T.

J Biomol Tech. 2008 Sep;19(4):231-7.

31.

[Intestinal endometriosis].

González Rodríguez CI, Cires M, Jiménez FJ, Rubio T.

An Sist Sanit Navar. 2008 May-Aug;31(2):197-200. Spanish.

32.

[Merkel cell carcinoma. On one case].

Cires Bezanilla M, González CI, Jiménez FJ, Rubio T, Amat I.

An Sist Sanit Navar. 2008 May-Aug;31(2):193-6. Spanish.

33.

[A case of mesenteric panniculitis].

González CI, Cires M, Rubio T, Jiménez FJ, García de Eulate I, Artondo MT.

An Sist Sanit Navar. 2008 Jan-Apr;31(1):81-5. Spanish.

34.

Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab.

González V, Salgueiro E, Jimeno FJ, Hidalgo A, Rubio T, Manso G.

Pharmacoepidemiol Drug Saf. 2008 Jul;17(7):714-21. doi: 10.1002/pds.1587.

PMID:
18340626
35.

[Paget-Schroetter síndrome associated with hyperhomocsyteinemia].

González CI, Cires M, Rubio T, Jiménez F, Sarasíbar E, Gaztelu MT, González V.

An Sist Sanit Navar. 2007 Sep-Dec;30(3):469-74. Spanish.

36.

[Calcinosis cutis: on one case].

González CI, Calvo A, López N, Sarasibar H, Cires M, Jiménez F, Rubio T.

An Sist Sanit Navar. 2007 Jan-Apr;30(1):135-8. Spanish.

37.

Safety profile of proton pump inhibitors according to the spontaneous reports of suspected adverse reactions.

Salgueiro E, Rubio T, Hidalgo A, Manso G.

Int J Clin Pharmacol Ther. 2006 Nov;44(11):548-56.

PMID:
17176621
38.

Actin deficiency induces cofilin phosphorylation: proteome analysis of HeLa cells after beta-actin gene silencing.

Liu N, Academia K, Rubio T, Wehr T, Yeck T, Jordan L, Hamby K, Paulus A.

Cell Motil Cytoskeleton. 2007 Feb;64(2):110-20.

PMID:
17123313
39.

[Spontaneous pneumomediastinum].

Ruiz-Ruiz FJ, Sampériz A, Rubio T, Escolar F.

An Sist Sanit Navar. 2006 May-Aug;29(2):275-8. Spanish.

40.

[Non-invasive home mechanical ventilation in the COPD patient].

González Rodríguez CI, Jiménez Bermejo F, Rubio T, Godia S, Salinas U.

An Sist Sanit Navar. 2005 Sep-Dec;28(3):345-50. Spanish.

41.

[Abdominal tuberculosis].

Rubio T, Gaztelu MT, Calvo A, Repiso M, Sarasíbar H, Jiménez Bermejo F, Martínez Echeverría A.

An Sist Sanit Navar. 2005 May-Aug;28(2):257-60. Spanish.

42.

[Intestinal invagination in the adult secondary to jejunal lipoma].

Calvo AM, Montón S, Rubio T, Repiso M, Sarasibar H.

An Sist Sanit Navar. 2005 Jan-Mar;28(1):115-8. Spanish.

43.

[Progress in the control of HIV infection and AIDS in Navarre, 1985-2003].

Moreno-Iribas C, Irirsarri F, Elizalda I, Urtiaga M, Sola J, Fernández-Jaúregui C, Martínez De Artola V, Sáinz de Murieta J, Dorronsoro I, Rubio T, Castilla J.

An Sist Sanit Navar. 2004 May-Aug;27(2):221-31. Spanish.

44.

[Mechanisms of hypertension in obesity].

López de Fez CM, Gaztelu MT, Rubio T, Castaño A.

An Sist Sanit Navar. 2004 May-Aug;27(2):211-9. Review. Spanish.

45.

Abdominal actinomycosis with hydronephrosis in childhood.

Campo JM, Rubio TT, Churchill RB, Fisher RG.

Pediatr Infect Dis J. 2001 Sep;20(9):901-3.

PMID:
11734772
46.

Results of a home-based training program for patients with COPD.

Hernández MT, Rubio TM, Ruiz FO, Riera HS, Gil RS, Gómez JC.

Chest. 2000 Jul;118(1):106-14.

PMID:
10893367
47.

[49 Year-old woman with cutaneous lesion, hypoxemia and pulmonary mass].

Rubio T, Gaztelu MT, García C, Urbieta M, Alonso JL.

Enferm Infecc Microbiol Clin. 1999 May;17(5):247-8. Spanish. No abstract available.

PMID:
10396090
48.

Broad-spectrum protection against tombusviruses elicited by defective interfering RNAs in transgenic plants.

Rubio T, Borja M, Scholthof HB, Feldstein PA, Morris TJ, Jackson AO.

J Virol. 1999 Jun;73(6):5070-8.

49.

Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.

Smith AL, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Redding G, Rubio T, Williams-Warren J, Wilmott R, Wilson HD, Yogev R.

J Pediatr. 1999 Apr;134(4):413-21.

PMID:
10190914
50.

Restoration of wild-type virus by double recombination of tombusvirus mutants with a host transgene.

Borja M, Rubio T, Scholthof HB, Jackson AO.

Mol Plant Microbe Interact. 1999 Feb;12(2):153-62.

Supplemental Content

Support Center